AChE expression was also significantly higher in clinically diagnosed AD/MCI participants receiving cholinesterase inhibitors compared with untreated individuals (P=1.16×10−9; P<0.0001 after adjusting for diagnosis). This evidence concerns the gene BCHE and Alzheimer disease.